Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.38 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.38 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.36 |
| ▸ | FGFR2 | P21802 | 10/20 | 0.35 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.35 |
| ▸ | FGFR4 | P22455 | 2/20 | 0.35 |
| ▸ | FGFR3 | P22607 | 2/20 | 0.35 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25557483 | 0.95 | MAPT (0.38) | MAPTKDM4EMAOBADORA2AALDH1A1 | |
| SCHEMBL22696566 | 0.83 | RIPK1 (0.36) | MAPTKDM4EMAOBADORA2AALDH1A1 | |
| SCHEMBL22696564 | 0.83 | RIPK1 (0.37) | MAPTKDM4EMAOBADORA2AALDH1A1 | |
| SCHEMBL22696341 | 0.83 | KDM4E (0.39) | MAPTKDM4EMAOBADORA2AALDH1A1 | |
| SCHEMBL25557493 | 0.81 | RIPK1 (0.37) | NTRK1NTRK2TNK2FGFR1FGFR3 | |
| SCHEMBL25557504 | 0.81 | RIPK1 (0.36) | MAPTKDM4EMAOBADORA2AALDH1A1 | |
| SCHEMBL25557486 | 0.79 | KDM4E (0.37) | MAPTKDM4EMAOBADORA2AALDH1A1 | |
| SCHEMBL22696342 | 0.73 | FGFR1 (0.51) | MAPTKDM4EMAOBADORA2AALDH1A1 | |
| SCHEMBL25557491 | 0.68 | FGFR1 (0.47) | MAPTKDM4EMAOBADORA2AALDH1A1 | |
| SCHEMBL29535127 | 0.68 | FGFR2 (0.39) | FGFR2FGFR1FGFR4FGFR3RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174535-A1 | INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES | KINNATE BIOPHARMA INC. | 2023-06-08 | — | — | US | disclosed |
| WO-2020236524-A1 | INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES | KINNATE BIOPHARMA INC. (US) | 2020-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174535-A1 | INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES | FGFR1, FGFR2, FGFR3 | MAPT 3123/4885KDM4E 2504/4885MAOB 2901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.